BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) shares hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $1.79 and last traded at $1.74, with a volume of 14051 shares changing hands. The stock had previously closed at $1.74.
BioRestorative Therapies Stock Performance
The stock has a market capitalization of $2.85 billion, a PE ratio of -1.63 and a beta of 102.36. The firm’s fifty day moving average is $1.60 and its 200-day moving average is $1.53.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
See Also
- Five stocks we like better than BioRestorative Therapies
- Investing in Travel Stocks Benefits
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- What are earnings reports?
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Market Cap Calculator: How to Calculate Market Cap
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
